ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
Cash from Investing Activities
ImpediMed Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ImpediMed Ltd
ASX:IPD
|
Cash from Investing Activities
-AU$5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-53%
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Investing Activities
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Investing Activities
-AU$538k
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
3%
|
Cochlear Ltd
ASX:COH
|
Cash from Investing Activities
-AU$87.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Investing Activities
-AU$5m
|
CAGR 3-Years
-474%
|
CAGR 5-Years
-77%
|
CAGR 10-Years
N/A
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Investing Activities
-AU$187.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ImpediMed Ltd's Cash from Investing Activities?
Cash from Investing Activities
-5m
AUD
Based on the financial report for Dec 31, 2023, ImpediMed Ltd's Cash from Investing Activities amounts to -5m AUD.
What is ImpediMed Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-53%
Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for ImpediMed Ltd have been -36% over the past three years , -25% over the past five years , and -53% over the past ten years .